Compounds That Target MAP3K1

mitogen-activated protein kinase kinase kinase 1 · 27 compounds in BiohacksAI corpus

MAP3K1 (mitogen-activated protein kinase kinase kinase 1) is a biological target with 27 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into MAP3K1 modulation for therapeutic and biohacking applications.

View MAP3K1 target page →UniProt: Q13233 ↗

Most Studied Compounds for MAP3K1

Sorafenib

300+

studies

Crizotinib

298+

studies

All 27 Compounds — Ranked by Evidence

Erlotinib

5.55

confidence

Ponatinib

4.26

confidence

Ruxolitinib

4.23

confidence

Bosutinib

4.08

confidence

Pazopanib

3.69

confidence

Regorafenib

3.56

confidence

Baricitinib

3.56

confidence

Pelitinib

3.50

confidence

Tae 684

3.43

confidence

Ribociclib

3.26

confidence

At 9283

3.09

confidence

Lestaurtinib

3.04

confidence

Danusertib

2.94

confidence

Kw 2449

2.64

confidence

Ast 487

2.56

confidence

Gsk 461364

2.40

confidence

Cudc 101

2.40

confidence

Golvatinib

2.20

confidence

Rg 547

2.08

confidence

Ly 3009120

2.08

confidence

Tg100 115

2.08

confidence

Cyc 116

2.08

confidence

Icotinib

1.79

confidence

Pf 03814735

1.79

confidence

Osi 632

1.79

confidence

Crizotinib

298+

studies

1.10

confidence

Sorafenib

300+

studies

0.69

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for MAP3K1 (mitogen-activated protein kinase kinase kinase 1). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: MAP3K1 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.